US OptionsDetailed Quotes

GNPX240920P2500

Watchlist

0.00
0.000.00%

15min DelayTrading Jul 23 09:30 ET

0.00High0.00Low

Genprex Stock Discussion

TrendTrader

May 31 13:41

4 🎯 tap! Over solid will run.

$Genprex(GNPX.US)$

3.96 tap. Over 4 I think it pumps all the way to the next level 👀

$Genprex(GNPX.US)$
NEWS
Genprex Doses First Patient in Acclaim-3 Clinical Study of Reqorsa® Immunogene Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer
Genprex announced the first patient dosing in its Phase 1 Acclaim-3 clinical study of Reqorsa Immunogene Therapy in combination with Tecentriq to treat extensive-stage small cell lung cancer (ES-SCLC). This trial, which aims to determine the maximum tolerated dose for a Phase 2 expansion expected in the second half of 2024, ...